<DOC>
	<DOCNO>NCT00620568</DOCNO>
	<brief_summary>This randomize , inpatient , ascend multiple dose study assess safety tolerability SLV-313 SR tablet administer orally subject schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Study Evaluating Multiple Ascending Dose Schizophrenia Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Men , age 1850 year old Women , age 1850 year old Nonlactating woman , age 1850 year old Nonpregnant woman , age 1850 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>